PMCTPharmaCountry
    首页
    此标签暂无分类
关于我们
  • 关于 PharmaCountry
  • 运作方式
  • 合作伙伴
  • 可持续发展
  • 联系我们
买家专区
  • 搜索产品
  • 搜索服务
  • 寻找供应商
  • 寻找求职者
  • 帮助中心
  • 常见问题
  • 买家保障
卖家/服务提供商专区
  • 开始销售
  • 卖家指南
  • 价格方案
  • 广告
  • 卖家支持
热门分类
  • Active Pharmaceutical Ingredients (APIs)
  • Finished Dosage Forms
  • Manufacturing Equipment & Utilities
  • Excipients & Additives
  • 查看所有分类
保持联系

contact@pharmacountry.com

全天候客户支持

值得信赖的 B2B 平台
SSL 安全交易 认证供应商 质量保证 B2B 认证 全球网络
PMCTPharmaCountry
© 2026 PharmaCountry。保留所有权利。
隐私政策服务条款Cookie 政策
首页/资讯/每日新闻

每日新闻

来自制药行业的突发新闻和最新动态

每日新闻市场分析研究与报告法规更新
每日新闻
2026年5月22日•3 分钟阅读
WHO Calls for Greater Transparency in Pharmaceutical Pricing
The World Health Organization urges member states to adopt standardized frameworks for medicine pricing disclosure to improve market access globally.
每日新闻
2026年5月21日•3 分钟阅读
Pfizer Expands API Manufacturing Capacity in Singapore
Pfizer announces a $400M investment to expand active pharmaceutical ingredient production capabilities at its Singapore facility.
每日新闻
2026年5月20日•3 分钟阅读
Global Pharma Market Expected to Hit $1.9 Trillion by 2027
New industry forecasts project the global pharmaceutical market will surpass $1.9 trillion by 2027, driven by biologics growth and expanding emerging markets.
Global API Market Projected to Reach $245B by 2028每日新闻
2026年3月16日•3 分钟阅读
Global API Market Projected to Reach $245B by 2028
Growing demand for both small-molecule generics and biologic APIs is driving unprecedented investment in manufacturing capacity across Asia, Europe, and North America.
FDA Streamlines CDMO Inspection Framework for 2026每日新闻
2026年3月13日•3 分钟阅读
FDA Streamlines CDMO Inspection Framework for 2026
The FDA has announced a modernized inspection framework that prioritizes risk-based assessments, potentially reducing routine inspection frequency for high-compliance CDMOs.
Asia-Pacific CMO Capacity Doubles in Five Years每日新闻
2026年3月10日•3 分钟阅读
Asia-Pacific CMO Capacity Doubles in Five Years
Major capacity expansions across India, South Korea, and Southeast Asia are transforming the region into a global hub for contract pharmaceutical manufacturing.